ArticleJournal of thoracic disease2016
Risk guided use of the direct thrombin inhibitor bivalirudin: insights from recent trials and analyses.
William B Hillegass et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it